Analyst Ratings for Anthera Pharma (ANTH) [Buys]
ANTH Rating Summary
ANTH Price Target Summary
- Highest: $20.00 (Collins Stewart)
- Lowest: $2.00 (Jefferies)
- Average: $7.86
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.86 (+1188.1%)
Avg. $ Target:
$7.86 (+1188.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2013 | Jefferies | New Coverage | Buy (N/A) |
2.00 (N/A) |
0.57 | 0.61 | 7.02% | Details |
| 11/13/2012 | Leerink Swann | New Coverage | Outperform (N/A) |
3.00 (N/A) |
0.69 | 0.61 | -11.59% | Details |
| 3/2/2012 | Summer Street | New Coverage | Buy (N/A) |
15.00 (N/A) |
6.46 | 0.61 | -90.56% | Details |
| 12/8/2011 | Canaccord Genuity » Updated 7/9/2012 |
New Coverage | Buy (N/A) |
3.00 (6.00) |
6.75 | 0.61 | -90.96% | Details |
| 12/2/2011 | Wedbush | Upgrade | Outperform (N/A) |
8.00 (N/A) |
5.79 | 0.61 | -89.46% | Details |
| 12/2/2011 | Collins Stewart | New Coverage | Buy (N/A) |
20.00 (N/A) |
5.79 | 0.61 | -89.46% | Details |
| 11/1/2011 | Deutsche Bank » Updated 4/19/2012 |
New Coverage | Buy (N/A) |
4.00 (N/A) |
6.35 | 0.61 | -90.39% | Details |
